SCHEMBL31620

SCHEMBL31620

CC1(C)c2ccccc2-c2cc3c(cc21)c1ccccc1n3-c1ccc(N(c2ccccc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PER2 O15055 1/20 0.31
CRY1 Q16526 1/20 0.31
CRY2 Q49AN0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31790 0.97 KDM4E (0.32) KDM4EATML3MBTL1
SCHEMBL21369285 0.93 CAMK2D (0.32) KDM4EATML3MBTL1
SCHEMBL31829 0.93 KDM4E (0.39) KDM4EATML3MBTL1
SCHEMBL21370096 0.93 CAMK2D (0.30)
SCHEMBL21369284 0.92 CAMK2D (0.30)
SCHEMBL31649 0.91 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL12704807 0.91 KDM4E (0.34) KDM4EATML3MBTL1PER2CRY1
SCHEMBL31822 0.91
SCHEMBL21369334 0.91 HDAC4 (0.31) KDM4EATML3MBTL1
SCHEMBL21370091 0.90 CAMK2D (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9722185-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 US disclosed
US-9722185-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 US disclosed
US-20150295185-A1 MATERIAL FOR ORGANIC LIGHT EMITTING DEVICE, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-10-15 US disclosed
US-20150295185-A1 MATERIAL FOR ORGANIC LIGHT EMITTING DEVICE, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-10-15 US disclosed
US-20150041770-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-02-12 US disclosed
US-20150041770-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-02-12 US disclosed
WO-2012026780-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150295185-A1 MATERIAL FOR ORGANIC LIGHT EMITTING DEVICE, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME AOX1, ALDH1A2, ALDH1A1 KDM4E 1381/4885ATM 2459/4885L3MBTL1 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.